Table 1.
Myelolipoma: baseline measurements and endocrinological test results.
| Patient 1 | Patient 2 | Normal | |
|---|---|---|---|
| Baseline | |||
|
| |||
| ACTH, pmol/L | 6–32.8* | 10.9–94.2 | (2–13) |
| Cortisol, nmol/L | 210 | 387 | (250–750) |
| 17 OH-progesterone, nmol/L | >605 | 445 | (<6) |
| DHEAS, μmol/L | 14.4 | 1.8 | (6–12) |
| Androstendione, nmol/L | 43.8 | 10.9 | (<5.6) |
| Testosterone, nmol/L | 11.7 | 10.1 | (10–40) |
|
| |||
| ACTH stimulation** | |||
|
| |||
| Cortisol 30 minutes, nmol/L | 211 | 409 | |
| Cortisol 60 minutes, nmol/L | 231 | 412 | (>550) |
| 17 OH-progesterone 30 minutes, nmol/L | >605 | 445 | |
| 17 OH-progesterone 60 minutes, nmol/L | >605 | 560 | (<30) |
|
| |||
| Dexamethasone suppression*** | |||
|
| |||
| Cortisol, nmol/L | 22 | 45 | (<50) |
| 17 OH-progesterone, nmol/L | 14.3 | 18.8 | |
*Most values in the higher range. **Corticotropin (250 ug i.v.). ***1 mg overnight test in Patient 2 and 0.5 mg × 4 for 2 days in Patient 1.